Skip to main content
Premium Trial:

Request an Annual Quote

European Consortium Solicits Formal Comment from Prospective Node Hosts

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A European consortium looking to build an integrated bioinformatics network is seeking comment from organizations interested in hosting nodes within the network.

European Life-Science Infrastructure for Biological Information, or ELIXIR, said Wednesday that it is seeking suggestions for providing pan-European capability in one or more of the following areas: data resources; biocomputing centers; an infrastructure for integration of biological data, software, tools and services; and services for the research community, including training and standards development.

ELIXIR has set a July 12 deadline for submission of comments.

ELIXIR is a consortium of 32 research organizations, universities, and companies from 14 countries plus the European Molecular Biology Laboratory. The consortium is led by EMBL's European Bioinformatics Institute, which will host the network's central hub at its facility on the Wellcome Trust Genome Campus in Hinxton, UK.

"Responses from this round of stakeholder input will enable ELIXIR's Steering Committee to define the landscape of potential nodes, provide the coordination necessary to ensure interoperability, and identify any duplications and missing capabilities," EMBL-EBI said in a statement.

Funds for ELIXIR will come from research funding agencies in the consortium's member states, which will decide how much to spend, and develop their own processes for reviewing proposals. ELIXIR was one of several initiatives proposed in the European Roadmap for Research Infrastructures, first published in 2006 with an update in 2008.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.